Tuesday, 23 April 2019

Home Healthcare Market owing to increasing healthcare costs and the burgeoning geriatric population

Market Synopsis:
Market Research Future (MRFR)’s new study projects that the global home healthcare market is set to expand at a CAGR of 8.1% during the forecast period 2017 to 2023. The valuation of the global market is expected to reach USD 4,14,681.2 Mn by the end of 2023. A rapid inclination towards home healthcare services has been witnessed recently which has led to the growth of the global home healthcare market. The market is expected to encounter a similar trend over the next couple of years.
The rising geriatric population coupled with rising healthcare expenditure is likely to drive the proliferation of the home healthcare market during the projection period. Furthermore, homecare solutions have emerged as a cost-effective alternative to expensive stay in hospitals. It is likely to augment the home healthcare market in the foreseeable future.
The unavailability of trained professionals at the eleventh hour remains an impediment to the market expansion. However, the market participants are focusing on technological advancements that enable instant consultation with skilled professionals at crucial moments. The future of the market looks attractive with technological innovations and government support paving the way for new growth opportunities.
Market Segmentation:
By product, the home healthcare market is segmented into testing, screening and monitoring products and therapeutic products.
By service, the home healthcare market has been segmented into skilled nursing services, rehabilitation therapy services, unskilled care services, respiratory therapy services, infusion therapy services, and pregnancy care services.
By software, the home healthcare market has been segmented into clinical management systems, agency software, telehealth solutions, and hospice solutions.
Regional Insights:
The home healthcare market, by region, has been segmented into Americas, Europe, Asia Pacific, and the Middle East and Africa. Americas holds the major share of the global market and is poised to retain its pole position towards the end of the assessment period. The factors that are favoring the proliferation of the home healthcare market in the region include the consolidation of key players, increasing healthcare expenditure, the large-scale prevalence of chronic diseases, growing government initiatives, etc. The regional market encompasses North America and South America, out of which, North America’s home healthcare market is likely to exhibit a relatively higher growth rate over the next couple of years.
Europe has secured the second spot in the global home healthcare market. It is expected to grow substantially in the forthcoming years due to the presence of well-developed technologies and increasing support from government and private organizations for research & development.
Asia Pacific is projected to strike the highest CAGR over the assessment period. The growth-inducing factors supporting the regional home healthcare market include growing geriatric population, huge patient pool, and availability of skilled labor force. Meanwhile, the Middle East & Africa is prognosticated to account for the least share of the home healthcare market owing to the prevailing poor economic conditions, especially in the African region.
Competitive Dashboard:
Some of the key players profiled in this report are Koninklijke Philips N.V. (The Netherlands), A&D Company (Japan), Fresenius SE & Co KGaA (Germany), F. Hoffmann-La Roche AG (Switzerland), Abbott (U.S.), B. Braun Melsungen AG (Germany), Becton Dickinson Company (U.S.), GE Healthcare (U.S.), McKesson Corporation (U.S.), Omron Corporation (Japan), LG Electronics (South Korea), Kinnser Software (U.S.), Medtronic PLC (U.S.), Apple (U.S.), and 3M (U.S.).
Industry News:
In October 2018, Tower Health, which owns Reading Hospital in the U.S., has announced the reorganization and expansion of its home health services that enables a patient to recover from home.
In November 2018, Dubai Health Authority (DHA) has launched smart home care technologies that allow home care team to contact doctors via smart applications for instant consultation.
In November 2018, the Centers for Medicare and Medicaid Services has announced the launch of a new value-based payment system for home health agencies.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels: , , , , , ,

Monday, 22 April 2019

Automated Suturing Devices Market Trends, Drivers, Strategies, Applications and Competitive Landscape 2023

Automated Suturing Devices market-Overview

Sutures are sterile surgical instruments used for the closure of surgical incision or wound. Sutures are either automated or manually operated devices. Demand for automated suturing devices is increasing due to an increase in the number of surgeries performed in the hospital, demand of safe closure of surgical site, prevention of hospital acquired infection, and improved quality of healthcare.

Get Free Sample PDF @ https://www.marketresearchfuture.com/sample_request/1207

There is an increasing demand for automated suturing devices in the market owing to an increasing number of surgical procedures in hospitals and rising prevalence of chronic diseases. The market is further stimulated by a technology advancement in surgical devices having applications in various fields of medicine such as dentistry, gynaecology, cardiology, urology, and others.

Key Players in the Automated Suturing Devices market:
Key players in the automated devices market are Ethicon Inc. (Subsidiary of Johnson & Johnson) (U.S.), B. Braun Melsungen AG (Germany), Medtronic plc. (Ireland), DemeTECH Corporation (U.S.), Smith & Nephew plc (U.K.), Péters Surgical (France), EndoEvolution LLC (U.S.), Boston Scientific Corporation (U.S.) and Sutures India Pvt. Ltd. (India). The main focus of these players is tapping the market in developing regions across the globe.
Key developments:
Strategic approaches adopted help the major players in the market to sustain their growth and develop their business in various geographical areas across the globe. Agreements and collaborations, mergers and acquisitions, and new product launches are various strategies followed by the key players.
Ethicon Inc.:
Ethicon Inc. is a subsidiary of Johnson & Johnson, manufacturing surgical sutures and wound closure devices. Enseal X1 is a suturing devices designed for use in open surgical procedures. Harmonic HD 1000 is designed of laparoscopic surgery.
  • February 2017: Ethicon, Inc. today announced an agreement to acquire Torax Medical, Inc., a private medical device company manufacturing and marketing the LINX Reflux Management System, a novel minimally invasive device for the surgical treatment of GERD. This acquisition will enable the company to offer patients effective alternative to the anatomy-altering laparoscopic Nissen fundoplication surgical procedure. LINX Reflux Management System comprises of interlinked titanium beads with magnetic cores. LINX is currently used by physicians in over 300 hospitals in the U.S. and Europe. This acquisition is a part of strategic approach advancement in innovation and investment in esophageal health.
  1. Braun Melsungen AG:
  2. Braun Melsungen AG is a medical and pharmaceutical device company.
  • Safil parenchyma Set, Securex, Securex are special suture sets offered by the company.
  • April 2017: B. Braun Melsungen AG announced the launch of new home infusion therapy application that will help healthcare professionals and patients. This app allows infusion therapy nurses to educate the patients to use Easypump at their own homes.
  • October, 2015: B. Braun Medical Inc., announced that it will the launch its latest advancement in echogenic peripheral nerve block needle technology at American Society of Anesthesiologists (ASA) Annual Meeting at the San Diego Convention Center. The product “Stimuplex Ultra 360” denotes an key advancement in regional anesthesia.
Medtronic plc.:
Founded in 1949, Medtronic plc is a global healthcare solutions company committed to improving the lives of people through their medical technologies, services, and solutions.
  • October, 2016: Medtronics plc. received an approval for its suite of cardiac rhythm and heart failure devices and leads to be scanned in both 3 and 1.5 Tesla (T) magnetic resonance imaging (MRI) machines. This FDA approval will help the company to strengthen its position in MRI machines segment.
  • December, 2015: Medtronic plc. and Samsung came together in an alliance to accelerate the development of digital health solutions for the millions of people suffering from chronic pain, movement disorders, incontinence, and other conditions who could benefit from neuromodulation therapy. Due to this Medtronics seeks to deliver real-time data to the patients and the physicians so they effectively find the cure for the tracked symptoms.
Boston Scientific Corporation:
Boston Scientific Corporation is a worldwide developer, manufacturer and marketer of medical devices used in a range of interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, electrophysiology, cardiac surgery, oncology, urology and others.
  • October, 2017: Boston Scientific Corporation announced an agreement to acquire Apama Medical Inc., a privately-held company, developing the Apama Radiofrequency (RF) Balloon Catheter System for the treatment of atrial fibrillation (AF). Through this acuquistion the company desires to invest in the electrophysiology category and to expand the product portfolio of differentiated arrhythmia solutions.
Access Report Details @ https://www.marketresearchfuture.com/reports/automated-suturing-devices-market-1207
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
ContactMarket Research Future
Office №528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune — 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels: , , ,

Thursday, 18 April 2019

Needle Free Diabetes Care Market – The Biggest Trends to Watch out for 2017-2023

Needle-Free Diabetes Care Market – Overview
The global Needle-Free Diabetes Care Market is growing pervasively, mainly due to the augmenting demand for non-invasive treatment solutions.  The number of diabetic patients is exploding day by day due to the increasing prevalence of the disease. Moreover, factors such as the technological advancements happened in diabetic care are escalating the market on the global level, bringing about novel devices.
Acknowledging the exponential growth, the market perceives currently, Market Research Future (MRFR) in its recently published study report asserts that the global needle-free diabetes care market will witness exponential accruals by 2023, registering 7.5% CAGR throughout the forecast period (2017-2023).
Additionally, factors such as the huge research funding in diabetes diagnosis & treatment and the rising number of approvals from regulatory bodies are boosting the growth of the market. Also, huge technological advancements and the vast uptake of smart technology to develop advanced devices in diabetic care drives the growth of the market.

FREE SAMPLE COPY OF “Needle-Free Diabetes Care Market Research Report- Forecast To 2023” @ https://www.marketresearchfuture.com/sample_request/912

On the other hand, factors such as the lack of awareness among people towards the availability of these care solution are hampering the growth of the market. Also, the high cost associated with the devices used in the needle-free diabetic care and the stringent FDA approvals & reimbursement policies are some of the factors impeding the growth of the market.
Nevertheless, augmenting demand for painless diabetic care are expected to support market growth over the forecast period.Furthermore, the increasing number of obese populations, increasing healthcare expenditure, and strong encouragement from the government are boosting the growth of the market.
Competitive Analysis
Highly competitive, the needle-free diabetes care market appears to be widely expanded and fragmented characterized by several small and large-scale players. To gain a competitive edge and to sustain their position in the market, these players incorporate various strategic initiatives such as partnership, acquisition, collaboration, expansion, and product launch.
Leading Key Players
Key players leading the global needle-free diabetes care market include Bioject Medical Technologies Inc. (US), Antares Pharma, Inc. (US), Endo International plc (US), PharmaJet (US), European Pharma Group (Netherland), Medical International Technology, Inc. (US), PenJet Corporation (US), Valeritas, Inc. (US), INJEX Pharma AG (Germany), Crossject SA (France), National Medical Products Inc. (US), Zogenix, Inc. (US), and 3M Company (US) among others.

Global Needle-Free Diabetes Care Market – Segments
  • For enhanced understanding, the market has been segmented into five key dynamics: –
  • By Devices Types             : Treatment Devices and Diagnostic Devices.
  • By Treatment    : Oral Insulin, Inhaled Insulin, and Insulin Patch among others.
  • By Application  : Insulin Delivery and other
  • By End-users      : Diagnostic Centers, Hospitals & Clinics and Other
  • By Regions                          : Asia Pacific, Europe, North America, and the Rest-of-the-World.

Detailed Geographical Analysis
The North American region, heading with the presence of a vast patient population accounts for the leading position in the global needle-free diabetes care market followed by the European and Asia Pacific regions, respectively. Moreover, factors as the presence of well-developed healthcare infrastructure and the leading players alongside the growing demand for the non-invasive treatment procedures substantiate the growth of the regional market.
Furthermore, the high prevalence of diabetes and support from the companies, private organization, and government associations to improve diabetes care along with the high healthcare expenditure in the region drive the regional market.


The needle-free diabetes care market in the European region holds the second-largest position, globally.  Furthermore, the resurging economy in the European region is playing an important role in supporting the market growth by availing the best possible healthcare, increasing healthcare expenditures.  Moreover, factors such as the government support that encourage the manufacturers of devices to develop high-quality devices and equipment used in diabetes care are fostering the growth in the regional market.
The Asia Pacific needle-free diabetes care market is rapidly emerging as a profitable market due to the increasing number of diabetic patients and the proliferating healthcare sector. Moreover, factors such as the spreading awareness among individuals towards the advantages and the availability of needle-free diabetes care drive the market growth in the region.
Industry News
March 12th, 2019 ––– Letko Brosseau & Associates Inc. (the US), an independent investment manager announced the acquisition of 990 Shares in Becton Dickinson and Company (BDX the US), medical technology company and medical instruments supplier, valuing at approximately USD 223 MN.
BDX is well-established company manufacturing and selling a wide range of medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The company’s BD Medical segment is also active in needle-free diabetes care, providing equipment such as automated medication dispensing, automated supply management systems, medication inventory optimization, and tracking systems.
September 11, 2018 —- QS Medical Technology Co., Ltd. (China), a leading medical equipment manufacturing company launched a new needle-free injection technology that is highly-effective and potentially more comfortable for patients with diabetes.
Emphasizing on developing innovative medical products to make life more comfortable, QS had partnered with Covestro to produce high-quality, needle-free injectors that can meet the needs of millions of diabetic patients in China and around the world.

About Us:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels: , , ,

Wednesday, 17 April 2019

Cardiac Catheterization Market Opportunities, Drivers, Manufacturers, Analysis and Forecasts Till 2023

The global Cardiac Catheterization Market is accruing pervasively mainly due to the growing rate of cardiovascular disorders, worldwide. Currently, the world is witnessing the increasing number of cardiac disorders cases and issues related to heart diseases. Sadly, the figure is expected to grow every year; despite the several innovative therapies and procedures. The rising prevalence of these diseases is becoming a major concern fuelling the growth of the global cardiac catheterization market.
Acknowledging the fiercely ascending market, Market Research Future (MRFR) in its recently published study report asserts that the global cardiac catheterization market will continue to grow by 2023, registering a CAGR of 9.2% during the forecast period (2017-2023).
Rising technological advancements transpired in the field of heart care, bringing a diversity of engineering and design backgrounds, privacy, liability, and financial perspectives necessary to succeed in a complex health care system. Global Cardiac Catheterization market is growing as continuously increasing the patients suffering from arterial diseases. Changing lifestyle, an increasing number of the patient suffering from obesity and diabetes has also helped to expand the market of the cardiac catheterization market.
On the other hand, stringent regulations and reimbursement issues in many countries are some of the dominant factors obstructing market growth. Also, the lack of skilled healthcare professionals is expected to the hamper the market growth.
Cardiac Catheterization Market – Segments
The market is segmented into five Key dynamics for an easy grasp.
By Procedures        : Balloon Septostomy, Coronary Angioplasty, Catheter Ablation, Bipolar Pacing, Left Heart Catheterization, and Right Heart Catheterization among others.
By Types                   : Fractional Flow Reserve, Coronary Angiogram, Intravascular Ultrasound, and Optical Coherence Tomography among others.
By Applications     : Heart Attack, Abnormal Stress Test, Coronary Vasospasm, and Cardiac Arrhythmia, among others.
By End-Users          : Hospitals and Clinics among others.
By Regions              : Comprises Geographical regions - North America, Europe, APAC and Rest of the World.

Cardiac Catheterization Market   - Regional Analysis
The North American region accounts for the global leader for the cardiac catheterization market owing to the increasing prevalence of cardiovascular diseases among the rising geriatric population, vulnerability to hypertension and obesity issues leading to the heart diseases and disorders.  The market is constantly growing due to huge people suffering from major or minor heart issues.
Additional factors substantiating the market growth include increasing government initiatives and funding for research, rising demand for technologically advanced cardiac catheterization treatments, and the developments in advanced medical treatment options.
The European region is the second-largest market for cardiac catheterization. Attributing to the increasing healthcare expenditure and availability of advanced treatment facilities, along with the government initiatives of healthcare, the European market is estimated to register a phenomenal CAGR during the forecast period.
Cardiovascular disease is one of the major concerns in Europe; it significantly contributes to the market growth in this region. Growing rate of cardiovascular disorders alongside government initiatives are expected to positively impact the market growth of the cardiac catheterization market in this region.
The Asia Pacific region is rapidly emerging as a promising market for cardiac catheterization. Increasing geriatric population alongside the prevalence of cardiac disorders and diabetes growing at an alarming rate is fostering the market growth in the APAC region.
Besides, the faster adaptation of healthcare technology, government initiatives to increase the healthcare quality, favorable insurance, and reimbursement policies are some of the other dominant factors driving the market growth. Furthermore, eminent key players are setting up their manufacturing plants in the emerging economies such as Singapore, China, Japan, Korea, and Australia, which, in turn, is propelling the growth of the cardiac catheterization market in this region.
Global Cardiac Catheterization Market   - Competitive Analysis
The market is fiercely competitive due to the presence of several large and small players forming a competitive edge in the market incorporating strategic partnership, collaboration, acquisition, expansion, and technology launch.  Significant investments are transpired in the field to bring innovations to the therapy and clinical trials. High growth potential demonstrated by the market is likely to attract several new entrants, this, in turn, will result in intensifying the market competition further.
Hospitals are investing heavily in R&D and clinical trials to develop a comprehensive, efficient, and state-of-the-art cardiac catheterization facility to provide tailor-made transplant surgeries based on the ailments, age, and other complications. With advanced diagnostics, and comprehensive rehabilitation schedule these hospitals ensure that the patient has access to the best care at every stage of the transplant journey.
Key Players:
Some of the eminent leaders of the market include Coloplast (Denmark), Boston Scientific Corporation (US), Dispocard GmbH (Germany), St. Jude Medical (US), Becton, Dickinson and Company (US), Abbott (US), Teleflex Incorporated (US)., Johnson & Johnson Private Limited (US), Smiths Medical (US), Medtronic Inc (US), Edwards Life Sciences Corporation (US), Rochester Medical Corporation (U.S), Terumo Medical Corporation (Japan), and Maquet Medical India Private Limited (India).
Industry/Innovations/Related News:
August 23, 2018 – Henry Ford Wyandotte Hospital (US) inaugurated a newly renovated cardiac catheterization lab. The state-of-the-art cardiac catheterization lab is designed to integrate technology, space, and workflow and to create a multi-sensor environment that operates efficiently to achieve a world-class care experience for patients, families, and staff. This move presages hospital’s another milestone in continuing to provide top-of-the-line healthcare to patients.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
 Contact:
Market Research Future+1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels: , , , ,

Sunday, 14 April 2019

Human Vaccines Market Top Players Share, Trend, Technology, Growth and Forecast to 2022

Market Overview:
Rapid advancement in technology is aiding the healthcare sector for development of innovative diagnostics and treatment solutions. Human vaccines are biological preparations that aid in improving immunity towards particular disease. Market Research Future (MRFR) has published a report stating that the Middle East and Africa Human Vaccines Market is marked to expand at a noteworthy CAGR of 11.8% during the forecast period of 2016-2022 and reach the valuation of USD 5.46 Bn by the end of the assessment period.
Market Drivers and Restraints:
Lack of awareness regarding the causative agents of diseases and low importance to sanitation and hygiene in the underdeveloped areas of Middle East and Africa region have led to the outbreak of various epidemics, causing major health concerns among the population of this region. Various diseases are being spread from these underdeveloped regions various parts of the world through the means of diseases carrying vectors. Multiple governmental and non-governmental organizations are taking the initiative of mass immunization in this region, which is majorly propelling the growth of the Middle East and Africa human vaccines market. 
Increasing investment for research and development for developing vaccines that are highly effective on endemic diseases such as Lassa fever, Ebola and others are fueling the expansion of the Middle East and Africa human vaccines market. Rise in disposable income and increased healthcare expenditure by the population of developed areas of this region are some other factors that are resulting in the significant expansion of the Middle East and Africa human vaccines market. However, lack of awareness and religious constraints towards vaccines are likely to act as a restraint on the expansion of the Middle East and Africa human vaccines market during the forecast period.
Market Segmentation:
The Middle East and Africa human vaccines market has been segmented on the basis of technology, disease indication, type, composition, route of administration and end user. Based on technology, the human vaccines market has been segmented into attenuated, inactivated, toxoid, conjugate and subunit and recombinant DNA. Based on disease indication, the human vaccines market has been segmented into pneumococcal, influenza, hepatitis, rotovirus, DTP, polio and others. Based on type, the human vaccine market has been segmented into prophylactic and therapeutic. Based on composition, the human vaccines market has been segmented into mono vaccine and combination vaccines. Based on route of administration, the human vaccines market has been segmented into oral, injectable and others. Based on end user, the human vaccines market has been segmented into children and adults.
Regional Analysis:
Geographically, the Middle East and Africa human vaccines market has been segmented into major countries such as UAE, Egypt, Saudi Arabia, Kuwait, Qatar and Oman. The UAE region commands for the major share in the Middle East and Africa human vaccine market owing to the rapid development of healthcare sector, increased investments for adoption of technologically advanced healthcare solutions and high healthcare expenditure in this region. The UAE region is closely followed by Egypt in case of market size. Huge unmet medical needs and increasing government initiatives for facilitating proper healthcare solutions in the underdeveloped countries of the African region are leading to the growth of the human vaccines market at the fastest rate in the Middle East and Africa human vaccines market.
Key Players:
The major players profiled by MRFR that are operating in the Middle East and Africa human vaccines market are GlaxoSmithKline Plc., Merck & Co. Inc., Pfizer, Inc., Shenzhen Kangtai Biological Products,  Sanofi Pasteur, Inc., AstraZeneca Plc., Bharat Biotech, Emergent Biosolutions Inc., Astellas Pharma Inc., Panacea Biotec Valeant Pharmaceuticals,  and others.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels: , , ,

Actinic Keratosis Treatment Market Size is Register at 4% CAGR By 2024

Actinic Keratosis Treatment Market to grow at 4% CAGR between 2018 and 2024

In a consumerist world, vacation on sea coast means catching a suntan, but tan can result in skin damage due to ultraviolet (UV) rays. Skin damage due to UV rays that can cause cancer is called actinic keratosis. In the atmosphere, the Ozone layer is thinning due to air pollution, and because of that, UV rays are increasing in the sunlight coming on Earth. With the danger of actinic keratosis rising, the market for its treatment is also expected to rise.


Market Research Future (MRFR) has published a report about global actinic keratosis treatment market. This report estimates 4% CAGR (Compound Average Growth Rate) during the forecast period between 2018 and 2024. In terms of cash, the revenue is expected to rise to US $ 6,088.4 mn in 2024. The report offers insights into the current competition in this market by observing key players. It has reviewed their company revenue, growth strategies, ongoing R&D activities, new mergers & acquisitions (M&A) activities, product launch, regional strength, segmental share, and SWOT. With actinic keratosis being more prevalent than ever, demand for its therapeutic medications has also gone up. Actinic keratosis remains an extremely common skin disorder, and its existence can be traced all over the world. However, people living in countries that have a hot climate, thinner ozone layer are more prone to this ailment. Delivery of cost-effective treatments and development of advanced therapeutics is expected to support the global actinic keratosis treatment market growth.
In this report, global actinic keratosis treatment market has been segmented on the basis of, end-user, medication, procedure, and region. End-users have been segmented into the ambulatory surgical center, dermatology clinics hospitals & oncology centers. Medication-based segmentation of this market covers diclofenac gel, fluorouracil cream, imiquimod cream, ingenol mebutate gel, and others. Procedure based segmentation includes cryotherapy, chemical peel, laser, photodynamic therapy and others.
Regional segmentation of global actinic keratosis treatment market comprises of the Americas (North America & South America), Asia Pacific, Europe and Middle East & Africa (MEA). Due to more health consciousness, advanced technology, and purchasing power, North America is a bigger market for actinic keratosis treatment than South America. Most of the key players in this market are based in the United States of America (USA) and Canada. In Europe market, due to advanced technology, higher purchasing power and more awareness regarding skin disorders, Western Europe is a bigger market than Eastern Europe. The Asia Pacific is a huge market due to more population and more people suffering from actinic keratosis who require treatment. Maximum revenue for the Asia Pacific market comes from Australia, China, and Japan. Remaining countries of Asia Pacific are also a sizable market for actinic keratosis treatment. After the Asia Pacific, the MEA region is the smallest market for actinic keratosis treatment due to lack of awareness, lack of technology and limited budget on healthcare.

Key Players
The key players in global actinic keratosis treatment market include 3M (USA), Alma Lasers (USA), Biofrontera AG (Germany), BioLineRx (Israel), Cipher Pharmaceuticals Inc. (Canada), Leo Pharma (Denmark), Pharmaceutical Industries Ltd. (India), Sun and Stanford Chemicals (USA) and Valeant Pharmaceuticals (Canada).
Latest Industry News
  • Celebrating successful Initial Public Offering (IPO) this year, Germany company Biofrontera, which is a key player in global actinic keratosis treatment market, has announced its plans for US expansion. Last year, the USA accounted for about 50% of the global sales of skin cancer drug Ameluz after it debuted in the market in October 2016. So the USA is a big market for Biofrontera’s actinic keratosis treatment.
  • French scientists at ‘Texinov Medical Textiles’ have developed a knitted laser fabric that blasts the skin with a light, giving treatment to inflamed skin or lesions over a 2 and a half hour appointment. With results of clinical trials being positive, the painless laser fabric has the strongest chance of entering the market as the quickest device to eradicate unwanted skin conditions, with no side effects. Initially, this device was developed to cure skin disorders such as acne, Paget’s disease, psoriasis, and other diseases like baby jaundice.

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:Market Research Future
Office №528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune — 411028
Maharashtra, India
+1 646 845 9312
Posted by at No comments:
Labels: , , , ,

Friday, 12 April 2019

Bariatric surgery Market Increasing Focus On Healthcare Sector For The Market Growth

Market Highlights
Bariatric surgery is widely used for the treatment of obesity worldwide.  Gastric bypass is the most popular type of bariatric surgery across the globe. Other type of procedures are an adjustable gastric band and biliopancreatic diversion with duodenal switch. Various devices are used for the surgery such as surgical stapler gastric bands, gastric balloons, gastric emptying systems, and electrical stimulation systems. Bariatric surgery is recommended for the people with BMI above 40. Obesity is one of the major risk factors for diabetes and cardiovascular diseases, thereby has a huge impact on the lives of the people across the globe.
The global Bariatric Surgery Market is expected to grow with a CAGR of 6.5% during the forecast period.
Some of the key players in the global market are Apollo Endosurgery Inc., Johnson & Johnson Services Inc., Olympus Corporation, ALLERGAN, TransEnterix Surgical, Inc., Cousin Biotech, EndoGastric Solutions, Inc., ReShape Lifesciences, Inc., Medtronic, Intuitive Surgical, Aspire Bariatrics, Mediflex Surgical Products and others.
Taste the market data and market information presented through more than 55 market data tables and figures spread over 101 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Bariatric surgery market research report–Global forecast till 2023.”
Major Players in Bariatric Surgery Market:
Regional Analysis
The American bariatric surgery market is the largest across the globe, which is mainly driven by the extensive use of surgical devices for bariatric surgery, the presence of major market players and rapid growth of healthcare sector. Awareness regarding obesity and physical fitness is found to be increasing among the U.S. population, thereby emphasizing the need for obesity management programs among the adult and geriatric population. The South American market is driven by the overall demand for innovative healthcare solutions in the market.
In Europe, Germany and France are the major contributors to the market growth. Expansion of healthcare industry, growing investment in medical device sector by major European nations and rising diabetic population drive the market.
Asia Pacific market exhibits high growth potential due to huge patient population and emergence of new market players. Rise in the share of healthcare in the GDP, and per capita income of people also accelerate the market growth. China is the hub of the huge geriatric population with a number of health conditions such as diabetes, obesity and cardiovascular diseases, further demanding the need for diagnosis and treatment services. In India, the obese population is expected to be at a high risk of diabetes and cardiovascular disease affecting their providing, necessitating the need for obesity managing among adults as well as the aging population.
The Middle East & Africa, a number of bariatric surgery are found to be increasing with an increase in the prevalence of chronic disease and increasing number of surgical centers in the region, boosting the market growth.
 Segmentation
The global bariatric surgery market is segmented on the basis of device, type, and end user.
On the basis of the device, the market is segmented into surgical stapler gastric bands, gastric balloons, gastric emptying systems, electrical stimulation systems and others.
On the basis of type, the market is segmented into gastric bypass, sleeve gastrectomy, adjustable gastric band, biliopancreatic diversion with duodenal switch, and others.
On the basis of the end user, the market is segmented into hospital & clinics, surgical centers, and others.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
 Contact:
Market Research Future
+1 646 845 9312
Posted by at No comments:
Labels: , , , , , ,
Subscribe to: Posts (Atom)